Dr Reddy’s share price trades flat ahead of Q4FY23 results; check details
Dr Reddy’s share price trades flat ahead of its Q4FY23 (January-March) results on Wednesday. The stock opened at the intraday high level of ₹4,931.50 per share on NSE.
Dr Reddy’s Laboratories is anticipated to release a good set of financial results for the quarter ended March 31, 2023. According to Zed Business Research, the pharmaceutical business is expected to record a 13% year-over-year (YoY) increase in its consolidated revenue to ₹6,174 crore from ₹5,475 crore logged in Q4FY2023.
The company announced a increase in net profit of 77% to ₹1,247 crore for the quarter that ended in December. In the past fiscal year’s December quarter, its net profit was ₹706,5 crore. Compared to Q3FY22, its overall operational income increased by 27% to ₹6770 crore.
The shares of the company
Know your inner investor
Do you have the nerves of steel or do you get insomniac over your investments? Let’s define your investment approach.
Take the test
Download The Mint News App to get Daily Market Updates.
More
Less
